| scholarly article | Q13442814 |
| P2093 | author name string | J H Kramer | |
| D Norman | |||
| M W Weiner | |||
| W J Jagust | |||
| D Mungas | |||
| N Schuff | |||
| W J Mack | |||
| L Willis | |||
| H C Chui | |||
| B R Reed | |||
| P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
| Staging of Alzheimer-related cortical destruction | Q34349510 | ||
| Neuropathological assessment of the lesions of significance in vascular dementia | Q36317478 | ||
| Strategic infarcts in vascular dementia. A clinical and brain imaging experience. | Q36705080 | ||
| Ischemic stroke and incomplete infarction | Q36797347 | ||
| Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease | Q37322618 | ||
| Leukoaraiosis and dementia in hypertensive patients | Q39232360 | ||
| Hippocampal MR imaging morphometry by means of general pattern matching | Q39422133 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease | Q39605803 | ||
| Vascular subcortical dementias: clinical aspects | Q40703812 | ||
| Is vascular dementia really Alzheimer's disease or mixed dementia? | Q41225706 | ||
| Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 | ||
| Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers | Q44026421 | ||
| Abstinent chronic crack-cocaine and crackcocaine/alcohol abusers evidence normal hippocampal volumes on MRI despite persistent cognitive impairments | Q46060061 | ||
| Dementia following strokes in the mesencephalon and diencephalon | Q48186182 | ||
| Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
| The effects of focal anterior and posterior brain lesions on verbal fluency | Q48451919 | ||
| Positron emission tomography in vascular dementia | Q48464725 | ||
| Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging | Q48613090 | ||
| Observations on the brains of demented old people | Q48896308 | ||
| The effects of additional pathology on the cognitive deficit in Alzheimer disease. | Q52044217 | ||
| The neuropsychology of paramedian thalamic infarction. | Q52068298 | ||
| A new clinical scale for the staging of dementia. | Q52220854 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. | Q53316862 | ||
| Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study | Q57782154 | ||
| Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type | Q68093532 | ||
| Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas | Q73028408 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| vascular disease | Q1266890 | ||
| magnetic resonance imaging | Q161238 | ||
| P304 | page(s) | 2229-2235 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease | |
| P478 | volume | 57 |
| Q36939456 | 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment |
| Q37774211 | A review of carotid atherosclerosis and vascular cognitive decline: a new understanding of the keys to symptomology. |
| Q33819499 | Age and education effects on relationships of cognitive test scores with brain structure in demographically diverse older persons |
| Q35606365 | Age effects on atrophy rates of entorhinal cortex and hippocampus |
| Q37204087 | Age effects on hippocampal structural changes in old men: the HAAS. |
| Q35184834 | Age-related white matter changes |
| Q47367180 | Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. |
| Q44408380 | Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients. |
| Q38973598 | Association between cardiovagal baroreflex sensitivity and baseline cerebral perfusion of the hippocampus. |
| Q33829017 | Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study |
| Q28533723 | Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI |
| Q36976750 | BOLD fMRI in the white matter as a marker of aging and small vessel disease |
| Q37254102 | Blood pressure and cognition among older adults: a meta-analysis |
| Q48313217 | Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936. |
| Q33426571 | Cerebral atrophy in cerebrovascular disorders |
| Q88117873 | Cerebrovascular blood oxygenation level dependent pulsatility at baseline and following acute exercise among healthy adolescents |
| Q35742820 | Cerebrovascular disease, β-amyloid, and cognition in aging |
| Q35661748 | Characteristics of MR infarcts associated with dementia and cognitive function in the elderly |
| Q49100137 | Clinical significance of subcortical vascular disease in patients with mild cognitive impairment. |
| Q44417374 | Cognitive Impairment Is Related to Cerebral Lactate in Patients With Carotid Artery Occlusion and Ipsilateral Transient Ischemic Attacks |
| Q33878781 | Cognitive and neuroimaging predictors of instrumental activities of daily living |
| Q35750397 | Cognitive impact of subcortical vascular and Alzheimer's disease pathology |
| Q35480424 | Cognitive impairment and functional outcome after stroke associated with small vessel disease |
| Q47785040 | Cognitive impairment and hippocampal atrophy in chronic kidney disease |
| Q47559896 | Comparative effect of Camellia sinensis teas on object recognition test deficit and metabolic changes induced by cafeteria diet |
| Q35749798 | Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia |
| Q36824832 | Correlation of thyroid dysfunction and cognitive impairments induced by subcortical ischemic vascular disease |
| Q78059413 | Current awareness in geriatric psychiatry |
| Q48016762 | Deep microbleeds and periventricular white matter disintegrity are independent predictors of attention/executive dysfunction in non-dementia patients with small vessel disease |
| Q53574499 | Determinants of prestroke cognitive impairment in stroke associated with small vessel disease. |
| Q37539126 | Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression |
| Q35677181 | Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. |
| Q36593197 | Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition |
| Q83981720 | Differential verbal fluency deficits in the preclinical stages of Alzheimer's disease and vascular dementia |
| Q35479970 | Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis |
| Q30754852 | Diffusion-tensor imaging of cognitive performance |
| Q35750403 | Dissociations in hippocampal and frontal contributions to episodic memory performance |
| Q45225244 | Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease |
| Q46439014 | Do vascular lesions and related risk factors influence responsiveness to donepezil chloride in patients with Alzheimer's disease? |
| Q38472170 | Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease |
| Q35675069 | Endovascular middle cerebral artery occlusion in rats as a model for studying vascular dementia |
| Q48254693 | Evaluation of cerebellar and cerebral volume in migraine with aura: a stereological study |
| Q41888068 | Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS |
| Q48198966 | Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults. |
| Q35677185 | Forgetting in dementia with and without subcortical lacunes |
| Q64057803 | General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women |
| Q48426560 | Hemodynamic aspects of Alzheimer's disease |
| Q48876836 | Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. |
| Q37076115 | High-Fat-Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders |
| Q36582593 | Higher cortisol predicts less improvement in verbal memory performance after cardiac rehabilitation in patients with coronary artery disease |
| Q35638477 | Hippocampal atrophy in systemic lupus erythematosus |
| Q35012243 | Hippocampal shape analysis in Alzheimer's disease using functional data analysis. |
| Q36579657 | Hippocampal subfield volumetry in patients with subcortical vascular mild cognitive impairment |
| Q35677163 | Hippocampal volume and retention in Alzheimer's disease |
| Q34904762 | Hippocampal volume is an independent predictor of cognitive performance in CADASIL. |
| Q31110945 | Imaging biomarkers and their role in dementia clinical trials |
| Q30975605 | Imaging in psychiatric illnesses |
| Q91860896 | Imaging the evolution and pathophysiology of Alzheimer disease |
| Q58215227 | Locomoção, distúrbios neuropsiquiátricos e alterações do sono de pacientes com demência e seus cuidadores |
| Q37427395 | Longitudinal MRI and cognitive change in healthy elderly |
| Q35677200 | Longitudinal volumetric MRI change and rate of cognitive decline |
| Q37784483 | Management of Mixed Dementia |
| Q35116519 | Measuring cognitive reserve based on the decomposition of episodic memory variance |
| Q24670516 | Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study |
| Q37212346 | Memory and cognition in preclinical dementia: what we know and what we do not know |
| Q35677204 | Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia |
| Q48290806 | Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment. |
| Q35172333 | Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment |
| Q31046921 | N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease |
| Q30425315 | Neuroanatomical substrates of age-related cognitive decline |
| Q35567884 | Neuroimaging and cardiac correlates of cognitive function among patients with cardiac disease |
| Q51898273 | Neuroimaging and correlates of cognitive function among patients with heart failure. |
| Q27691820 | Neuroimaging biomarkers of neurodegenerative diseases and dementia |
| Q51932536 | Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease. |
| Q33279055 | Neuroimaging of white matter in aging and dementia |
| Q51896763 | Neuroimaging predictors of cognitive impairment in confluent white matter lesion: volumetric analyses of 99 brain regions. |
| Q30655992 | Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration |
| Q37057978 | Neuropathological basis of magnetic resonance images in aging and dementia |
| Q48864565 | Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old age. |
| Q33608116 | One-minute mental status examination for category fluency is more useful than mini-mental state examination to evaluate the reliability of insulin self-injection in elderly diabetic patients |
| Q30870116 | Pathological correlates of white matter hyperintensities on magnetic resonance imaging |
| Q91984197 | Perivascular spaces contribute to cognition beyond other small vessel disease markers |
| Q50655334 | Portuguese version of Wechsler Memory Scale-3rd edition's utility with demented elderly adults. |
| Q37335585 | Predicting the location of entorhinal cortex from MRI. |
| Q46874702 | Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease |
| Q51939789 | Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. |
| Q48686537 | Relationship between atrophy of the medial temporal areas and cognitive functions in elderly adults with mild cognitive impairment |
| Q34073224 | Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment |
| Q48880377 | Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment |
| Q45996545 | Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories. |
| Q50751496 | Silent stroke and cognitive decline in asymptomatic carotid stenosis revascularization. |
| Q34629862 | Subcortical hyperintensity volumetrics in Alzheimer's disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory |
| Q30810286 | Subcortical ischaemic vascular dementia |
| Q36156335 | Subcortical ischemic vascular dementia |
| Q36744430 | Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly |
| Q36953779 | The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia |
| Q48190060 | The age-related white matter changes scale correlates with cognitive impairment |
| Q37156631 | The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat. |
| Q36730292 | The enigma of vascular cognitive disorder and vascular dementia |
| Q38384343 | The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory |
| Q28709470 | The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective |
| Q51952392 | The neuropsychology of vascular dementia. |
| Q34484708 | The overlap between vascular disease and Alzheimer's disease--lessons from pathology |
| Q34989485 | The pathology of ischemic-vascular dementia: an update |
| Q49142541 | The relationship between inflammatory markers and post stroke cognitive impairment |
| Q36808830 | Therapeutic issues in vascular dementia: studies, designs and approaches |
| Q30594485 | Towards the automatic computational assessment of enlarged perivascular spaces on brain magnetic resonance images: a systematic review |
| Q34777661 | Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention |
| Q35151987 | Vascular dementia: distinguishing characteristics, treatment, and prevention |
| Q35019559 | Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study |
| Q35677208 | Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease |
| Q22251221 | Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity |
| Q92321340 | White Matter Hyperintensities Predict Cognitive Decline: A Community-Based Study |
| Q35489976 | White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. |
| Q30893715 | White matter hyperintensities, cognitive impairment and dementia: an update |
| Q31032250 | White matter integrity and cognitive dysfunction: Radiological and neuropsychological correlations |
| Q33635712 | White matter integrity and cortical metabolic associations in aging and dementia |
| Q51988607 | White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. |
| Q35844738 | White matter lesions impair frontal lobe function regardless of their location |
| Q53395713 | [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex]. |
Search more.